| CTRI Number |
CTRI/2023/08/056138 [Registered on: 04/08/2023] Trial Registered Prospectively |
| Last Modified On: |
04/08/2023 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
"A study to evaluate the efficacy of kharjura in Haemoglobin levels with special refernce to Rakta dhatu poshanakaala - A Clinical study" |
|
Scientific Title of Study
|
Clinical study of khajura on hemoglobin percentage with special reference to sushrutas rakta dhatu poshankal |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Supriya P Tonge |
| Designation |
Associate Professor, Dept of Kriya Sharira |
| Affiliation |
Shri Dhanwantry Ayurvedic College and Hospital, Sector 46-B, Chandigarh |
| Address |
PZETs College of Ayurveda and Research Centre, Akurdi, Pune Shri Dhanwantry Ayurvedic College and Hospital, Sector 46-B, Chandigarh Pune MAHARASHTRA 411044 India |
| Phone |
8308252487 |
| Fax |
|
| Email |
supriyatonge1@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Swati Chobhe |
| Designation |
Professor and HOD, Department of Kriya Sharira |
| Affiliation |
PZETs College of Ayurveda and Research Centre, Akurdi, Pune |
| Address |
PZET College of Ayurveda and Research Centre, Akurdi, Pune PZET College of Ayurveda and Research Centre, Akurdi, Pune Pune MAHARASHTRA 411044 India |
| Phone |
9850716124 |
| Fax |
|
| Email |
swatichobhe@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Swati Chobhe |
| Designation |
Professor and HOD, Department of Kriya Sharira |
| Affiliation |
PZETs College of Ayurveda and Research Centre, Akurdi, Pune |
| Address |
PZET College of Ayurveda and Research Centre, Akurdi, Pune PZET College of Ayurveda and Research Centre, Akurdi, Pune
MAHARASHTRA 411044 India |
| Phone |
9850716124 |
| Fax |
|
| Email |
swatichobhe@yahoo.com |
|
|
Source of Monetary or Material Support
|
| shri dhanwantry ayurvedic college and hospital, chandigarh |
|
|
Primary Sponsor
|
| Name |
Dr Supriya Tonge |
| Address |
At post mukutban,zari jamani, district - yavatmal,state- Maharashtra |
| Type of Sponsor |
Other [other(self)] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| dr Supriya Tonge |
PDEAs College Of Ayurved And Research Centre |
Sector No. 27, Pradhikaran, Nigdi, Pimpri-Chinchwad, Maharashtra 411044 Pune MAHARASHTRA |
8308252487
supriyatonge1@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| PZET College of Ayurveda and Research Centre, Akurdi, Pune |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
person having lower haemoglobin levels (Borderline Anaemia) with classical sign and symptoms of Raktadhatu kshaya |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details |
|
| Intervention |
Group A - Khajur Laddu |
Khajur Laddu of 10 gram is administered once daily with Dhatri Loha of 250mg in empty morning for 30 days |
| Comparator Agent |
Group B- Dhatri Loha |
Dhatri Loha tablet of 250mg is administered once daily with anupana as ushna jala |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
30.00 Year(s) |
| Gender |
Both |
| Details |
1. Persons with lower levels of Hb (Borderline Anaemia of Hb 10 to 11gm%)
2. Persons presenting with signs and symptoms of Raktadhatu kshaya
3. Persons having proper agni bala
4. Persons will be selected from in and around the Research site of study without any bar of race, religion and sex |
|
| ExclusionCriteria |
| Details |
1. Persons below the age of 18years and above 30 years
2. Pregnant and lactating women
3. Persons suffering from any acute or chronic disease conditions
4. Persons suffering from Aplastic Anaemia, Pernicios Anaemia, Hemolytic Anaemia and other Haemoglobinopathies |
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Khajur laddu administered as neutraceutical is effective in improving Hb percentage in samples |
0th day, 5th day, 10th day, 15th day, 20th day, 25th day, 30th day with Hb evaluation |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| impact of khajura as nutritional supplementation on sushrutas rakta dhatu poshankal. |
0th day, 5th day, 10th day, 15th day, 20th day, 25th day, 30th day with Hb evaluation |
|
|
Target Sample Size
|
Total Sample Size="310" Sample Size from India="310"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3/ Phase 4 |
|
Date of First Enrollment (India)
|
17/08/2023 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
17/08/2023 |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
none yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
PURPOSE OF THE STUDY “To Assess Effect Of Khajura With Dhatriloha And Dhatriloha Alone On Haemoglobin Percentage With Special Reference To Sushrutas Rakta Dhatu Poshankal.†AIM To Compare The Effect Of Khajur With Dhatriloha And Dhatriloha Alone On Haemoglobin Percentage With Special Reference To Sushrutas Rakta Dhatu Poshankal.†OBJECTIVES Ø Primary objectives: - : To compare the effect of Khajura with dhatriloha and dhatriloha alone on Haemoglobin Percentage With Special Reference To Sushrutas Rakta Dhatu Poshankal. Ø Secondary objectives:- To study the impact of khajura as nutritional Supplementation on sushrutas rakta dhatu poshankal. Tools for Primary Objectives: 1. To assess the effect of Khajura with dhatriloha on Haemoglobin Percentage With Special Reference To Sushrutas Rakta Dhatu Poshankal. 2. To assess Probable mode of action of Khajura with dhatriloha and dhatriloha alone on Haemoglobin Percentage With Special Reference To Sushrutas Rakta Dhatu Poshankal. 3. To study the classical and recent literature regarding khajura, Collection and authentication of sample khajura. 4. Preparation of khajura laddu. 5. To Revalidate the Rakta dhatu shaya lakshanas “Raktemlashishirapriti†in rakta dhatu shaya. 6. Haemoglobin percentage was estimated by using sahli‟s haemoglobinometer or lab test. 7. Complete Blood Count (CBC) 8. To study the impact of khajura as Nutritional supplementation on Haemoglobin level. 9. To study the impact of khajura as Nutritional supplementation on Sushrutas Rakta Dhatu Poshan kala. 10. To study whether individual having Rakta kshaya has craving for Amlasheet Dravya. MATERIALS AND METHOD MATERIALS – 1. Khajura laddu – Self Prepared by Investigator. 2. Haemoglobin percentage - Sahli‟s Hemoglobinometer. 3. Complete Blood Count (CBC Count) METHODOLOGY 1) Type of Study Design – Open Randomized Controlled clinical study 2) Randomization procedure - Samples will be collected by Random sampling and labelled them 3) Place of study – Researcher concern places. 4) Duration of Study (Setting) - 3 Yrs. 5) Statistical analysis – Inference will be drawn by applying this test – Paired„t‟ test. 6) Sample size – 310 Patient15 PLAN FOR THE STUDY Ø The patients in the study will be selected randomly from respective study centre in same season. Ø 310 patient15 divided in 2 groups will be taken on the basis of inclusion and exclusion criteria i.e. assessment criteria. Ø Each patient will be thoroughly examined according to CRF. Ø Hb% and CBC count will be measured by lab test before and after 30days Ø Two group will be done, one group will be administered khajura with dhatriloha and another group will be administered only dhatriloha. Ø On every 5th day only haemoglobin percentage will be measured. Ø A haemoglobin level of male less than 13g/dl and female less than 12 g/dl has been defined as border line anaemia so Border line anaemic patient will be selected. Ø Khajura laddu in 10 gram will be administered at Rasayan kala (In early morning on empty stomach) every day total 30 day. Ø Duration of administration of Khajura laddu is 30 days. Ø The patient will be assessed on the basis of Haemoglobin percentage and grading scales are adopted to assess the grading system of rakta dhatu shaya lakshana. • Duration of treatment – 1month All the selected patients fulfilling the criteria of selection will be randomly Divided into two groups – I. Group A : This group will be termed as Experimental / Trial group. a) No. of patients : About 155 patients b) Treatment : This group will be administered Khajura laddu with dhatriloha26 c) Praman 1. Khajura laddu in 10 gram of khajura laddu will be administered at Rasayan kala (in early morning on empty stomach) every day. (Manufactured by company - Khajura marketed by Lion Company ISO certified- Highly accepted, rated and tested product. FSSAI certified) 2. Dhatriloha - 1 tab of 250 milligram Manufactured by company - Baidyanath Company d) Duration – 30 day ii) Group B : This group will be termed as control group. a) No of patients : About 155 patients. b) Treatment : This group will be administrating with only dhatriloha. c) Praman : Dhatriloha – 1 tab of 250 milligram. d) Duration – 30 day (Dhatriloha – Ref- Bhaishajya Ratnavali Pandurogadhikar) Treatment Schedule for 2 Groups Screening and selection of the patients will be carried out as per inclusion and exclusion criteria. Screening for selection criteria 
Included for Study with Investigation Day 0 Randomization - Samples will be collected by Random sampling and labelled them. Group A Experimental Group Group B control group
Follow up every day for administration of khajura laddu. On every 5th day only haemoglobin percentage will be measured also Investigation on 5th day and 30th day by lab test - hb% and CBC will be done Statistical analysis with Appropriate test Interpretation of Result S.O.P Of Khajura Laddu :- 1) Preparation – Self Prepared by Investigator. 2) Procedure – a) Manually removal of seed from khajura. b) Grinding of khajura in mixer grinder. c) Obtaining khajura paste and then lastly prepared khajura laddu 3) Diet – Routine diet. |